Forian Inc.
Forian Inc. provides healthcare equipment and technology solutions, primarily serving the medical industry.
Business. Forian Inc. (NASDAQ: FORA.O) is a healthcare company operating in the Advanced Medical Equipment & Technology industry, primarily engaged in the sale of healthcare equipment. The firm is headquartered in the United States and is listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
Analyst recommendations
1 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Forian Inc. (NASDAQ: FORA.O) is a healthcare company operating in the Advanced Medical Equipment & Technology industry, primarily engaged in the sale of healthcare equipment. The firm is headquartered in the United States and is listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
Forian Inc. has a market capitalization of $63.42 million and a price-to-book ratio of 2.13, indicating a premium valuation relative to its book value. The company's liquidity position is strong, with a current ratio of 2.97, suggesting it can comfortably meet its short-term obligations. However, the company has no long-term debt, and its debt-to-equity ratio is 0.0, indicating a conservative capital structure.
The company's profitability metrics are concerning, with a negative return on equity of -9.65% and a return on assets of -6.51%, both significantly below industry norms. Operating income was -$3.76 million, and net income was -$2.87 million, reflecting ongoing operational challenges. Gross profit of $16.10 million was insufficient to offset operating expenses, contributing to the net loss.
Forian Inc. generates revenue from its healthcare equipment and technology solutions, though the financial data does not provide a breakdown of revenue by segment or geographic region. The company's revenue for the latest period was $30.26 million, but the outlook for future growth is not specified in the available data.
The company's free cash flow was negative at -$2.67 million, indicating that it is not generating sufficient cash from operations to fund its capital expenditures and other obligations. Analysts have assigned a mean price target of $2.10, which is slightly below the current market price of $2.15, suggesting a neutral outlook. The mean recommendation of 3.00 (on a scale from 1 to 5) further supports a neutral stance, with no strong buy or buy ratings.
There are no immediate filing-based liquidity or dilution flags, and the risk assessment indicates low liquidity and dilution risks. The company's capital structure is currently free of dilution pressures, with no near-term dilution expected. The absence of long-term debt and the strong current ratio suggest that the company is in a stable financial position.
Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company's operating cash flow of $2.89 million provides some cushion, but it is not enough to offset the negative free cash flow. The company's total assets of $44.13 million and total equity of $29.78 million suggest a solid asset base, but the negative returns on equity and assets highlight the need for operational improvements.
- Forian Inc. has a strong liquidity position with a current ratio of 2.97 and no long-term debt.
- The company is currently unprofitable, with a negative return on equity of -9.65% and a net loss of $2.87 million.
- Analysts have a neutral outlook, with a mean price target of $2.10 and a mean recommendation of 3.00.
- The company's free cash flow is negative at -$2.67 million, indicating cash flow challenges.
- There are no immediate liquidity or dilution risks, and the company's capital structure is conservative.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,09 |
| Revenue | —no estimate | —no estimate | 32,2M USD |
| Operating income | —no estimate | —no estimate | -2,2M USD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Return On Equitynet_income / total_equity
- Price To Tangible Bookmarket_price / (tangible_book_value / shares_outstanding_diluted)
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Forian Inc. Market data — financials · 2026-05-27
- Forian Inc. Market data — analyst estimates · 2026-05-27
- Forian Inc. Market data — ESG · 2026-05-27
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2025-12-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2024-06-300,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Net margin (FY 2025-12-31): -9.5%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 0.48xDerived (calculated)
- Current ratio (FY 2025-12-31): 2.97xDerived (calculated)
- Return on assets (FY 2025-12-31): -6.5%Derived (calculated)
- Return on equity (FY 2025-12-31): -9.7%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 93.0%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 181.1%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 25.0%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 25.0%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): 23.8%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 920.6%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 46.1%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 101.9%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 50.1%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -0.9%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -6.4%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -16.2%Derived (calculated)
- Net income (annual): USD -2.87MSEC XBRL filing
- Shareholders' equity (annual): USD 29.78MSEC XBRL filing
- Revenue (annual): USD 30.26MSEC XBRL filing
- Pre-tax income (annual): USD -2.65MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES -0SEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES -0SEC XBRL filing
- Cash & equivalents (annual): USD 12.9MSEC XBRL filing